Canada
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 69.29 M
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
2 |
USD 39.70 M
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
3 |
USD 30.77 M
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
4 |
USD 9.53 M
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
5 |
USD 6.99 M
|
Dec. 31, 2023 | USD 6.23 | -0.19% |
|
Canada |
|
6 |
USD 6.07 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
7 |
USD 5.73 M
|
Dec. 31, 2023 | USD 2.85 | 2.89% |
|
Canada |
|
8 |
USD 2.98 M
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
9 |
USD 1.11 M
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
10 |
USD 1.05 M
|
March 31, 2024 | USD 1.14 | 2.02% |
|
Canada |
|
11 |
USD 38.86 K
|
Dec. 31, 2023 | USD 2.34 | -2.50% |
|
Canada |
|
12 |
USD 0.00
|
Aug. 31, 2024 | USD 1.86 | 5.08% |
|
Canada |
|
13 |
USD 0.00
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
14 |
USD 0.00
|
Oct. 31, 2024 | USD 6.90 | 1.77% |
|
Canada |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 39.98 | -1.21% |
|
Canada |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
18 |
USD 0.00
|
Sept. 30, 2023 | USD 1.91 | 1.06% |
|
Canada |
|
19 |
USD 0.00
|
Dec. 31, 2023 | USD 3.27 | 0.93% |
|
Canada |
The Biotechnology company in Canada with the highest Inventory is Knight Therapeutics Inc. (Toronto Stock Exchange: GUD.TO) at USD 69.29 M.
The Biotechnology company in Canada with the lowest Inventory is Achieve Life Sciences, Inc. (NasdaqCM: ACHV) at USD 0.00.
The top 10 Biotechnology companies in Canada by Inventory are Knight Therapeutics Inc., Aurinia Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., HLS Therapeutics Inc., Profound Medical Corp., Theratechnologies Inc., Sunshine Biopharma, Inc., Cipher Pharmaceuticals Inc., AbCellera Biologics Inc. and Zentek Ltd..
The bottom 10 Biotechnology companies in Canada by Inventory are Achieve Life Sciences, Inc., Edesa Biotech, Inc., Zymeworks Inc., XORTX Therapeutics Inc., Xenon Pharmaceuticals Inc., enGene Holdings Inc. Common Stock, Repare Therapeutics Inc., Lexaria Bioscience Corp., AgriFORCE Growing Systems Ltd. and Zentek Ltd..